Trial of Ketamine and Lithium Therapy in Bipolar Depression
Brief Summary
This study is looking at the safety and efficacy of combined ketamine and lithium therapy for treating patients with bipolar depression who are taking a mood stabilizer that is not working for them.
Condition or Disease
- Bipolar Depression
Phase
Study Design
| Study type: | Interventional |
|---|---|
| Status: | Withdrawn |
| Study results: | No Results Available |
| Age: | 18 Years to 65 Years (Adult, Older Adult) |
| Enrollment: | 0 () |
| Funded by: | Other|NIH |
Masking |
|
Clinical Trial Dates
| Start date: | Jan 13, 2020 | |
|---|---|---|
| Primary Completion: | Jan 13, 2020 | |
| Completion Date: | Jan 13, 2020 | |
| Study First Posted: | Jan 15, 2013 | |
| Results First Posted: | Aug 31, 2020 | |
| Last Updated: | Mar 09, 2020 |
Sponsors / Collaborators
Lead Sponsor:
N/A
Responsible Party:
N/A
Eligibility Criteria
| Sex: | All |
|---|---|
| Minimum Age: | 18 |
| Maximum Age: | 65 |
More Details
| NCT Number: | NCT01768767 |
|---|---|
| Other IDs: | 1209010758 |
| Study URL: | https://ClinicalTrials.gov/show/NCT01768767 |
Last updated: Mar 18, 2021